Literature DB >> 7737695

Regulation of nitric oxide synthesis in infectious and autoimmune diseases.

F Y Liew1.   

Abstract

Nitric oxide (NO) is an essential mediator for a variety of biological functions, including defence against a range of pathogens. However, excessive production of NO as a result of immunological stimulation, will lead to important immunopathologies. Therefore the production of NO is necessarily under tight regulation. The regulatory mechanisms so far known to control NO synthesis include cytokines (induction of NO synthase by IFN-gamma, TNF alpha, MIF and LPS, and down regulation by IL-4, IL-10 and TGF beta), feedback inhibition by NO itself, inhibition by pretreatment with LPS and glycoinositol-phospholipids and up regulation by lipophosphoglycan from the protozoa parasite, Leishmania major.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7737695     DOI: 10.1016/0165-2478(94)00157-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  16 in total

1.  Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice.

Authors:  L C Chen; J L Pace; S W Russell; D C Morrison
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Protective role of nitric oxide in Staphylococcus aureus infection in mice.

Authors:  S Sasaki; T Miura; S Nishikawa; K Yamada; M Hirasue; A Nakane
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.

Authors:  Aneesh Vijayan; Carmen E Gómez; Diego A Espinosa; Alan G Goodman; Lucas Sanchez-Sampedro; Carlos Oscar S Sorzano; Fidel Zavala; Mariano Esteban
Journal:  J Immunol       Date:  2012-05-21       Impact factor: 5.422

4.  Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae.

Authors:  I Ofek; A Mesika; M Kalina; Y Keisari; R Podschun; H Sahly; D Chang; D McGregor; E Crouch
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.

Authors:  Cláudia Maria Castro Gomes; Maria Gloria Teixeira Sousa; Joyce Prieto Bezerra Menezes; Marliane Campos Batista; Ana Carolina Stocco Lima; Walter Belda; Daniel Bradshaw; Monica Elinor Alves Gama; Márcia Dalastra Laurenti; Fernando Tobias Silveira; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2017-02-21       Impact factor: 2.289

6.  Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae.

Authors:  W C Tsai; R M Strieter; D A Zisman; J M Wilkowski; K A Bucknell; G H Chen; T J Standiford
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

7.  Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide.

Authors:  A Morikawa; N Koide; Y Kato; T Sugiyama; D Chakravortty; T Yoshida; T Yokochi
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

8.  Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus.

Authors:  Jennifer L Szczytkowski; Christina Lebonville; Lee Hutson; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2013-01-26       Impact factor: 7.217

9.  Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis.

Authors:  E Selvi; S A Tripodi; M Catenaccio; S Lorenzini; D Chindamo; S Manganelli; R Romagnoli; F Ietta; L Paulesu; C Miracco; M Cintorino; R Marcolongo
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

10.  Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.

Authors:  Ana Paula Galvão Da Silva; Jacqueline F Jacysyn; Ises De Almeida Abrahamsohn
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.